Skinvisible, Inc. (SKVI)
0.2021
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Skinvisible EPS Diluted (Quarterly) : -0.0473 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0473 |
| March 31, 2026 | -0.0494 |
| December 31, 2025 | -0.0478 |
| September 30, 2025 | -0.0463 |
| June 30, 2025 | -0.0508 |
| March 31, 2025 | -0.0524 |
| December 31, 2024 | 0.0592 |
| September 30, 2024 | -0.0631 |
| June 30, 2024 | -0.0668 |
| March 31, 2024 | -0.064 |
| December 31, 2023 | -0.0669 |
| September 30, 2023 | -0.0633 |
| June 30, 2023 | -0.0608 |
| March 31, 2023 | -0.3337 |
| December 31, 2022 | -0.0882 |
| September 30, 2022 | -0.0921 |
| June 30, 2022 | -0.0422 |
| March 31, 2022 | -0.0472 |
| December 31, 2021 | -0.0364 |
| September 30, 2021 | -0.0448 |
| June 30, 2021 | -0.06 |
| March 31, 2021 | -0.0959 |
| December 31, 2020 | -0.065 |
| September 30, 2020 | -0.0916 |
| June 30, 2020 | -0.07 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0962 |
| December 31, 2019 | -0.1256 |
| September 30, 2019 | -0.1204 |
| June 30, 2019 | -0.2013 |
| March 31, 2019 | -0.1184 |
| December 31, 2018 | -0.0615 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.137 |
| March 31, 2018 | 0.0345 |
| December 31, 2017 | -0.045 |
| September 30, 2017 | -0.2115 |
| June 30, 2017 | -0.50 |
| March 31, 2017 | -0.1935 |
| December 31, 2016 | -0.191 |
| September 30, 2016 | -0.205 |
| June 30, 2016 | -0.1995 |
| March 31, 2016 | -0.50 |
| December 31, 2015 | -0.216 |
| September 30, 2015 | -0.211 |
| June 30, 2015 | -0.2215 |
| March 31, 2015 | -0.226 |
| December 31, 2014 | -0.2775 |
| September 30, 2014 | -0.50 |
| June 30, 2014 | -0.1775 |
| March 31, 2014 | -0.1565 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medifast, Inc. | -0.2784 |
| Integrated BioPharma, Inc. | -0.044 |
| Nevis Brands, Inc. | -0.0043 |
| Functional Brands, Inc. | -0.0635 |
| Cyanotech Corp. | 0.0396 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2555M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 0.2605M |
| Enterprise Value | 6.951M |
| Profit Margin (Quarterly) | -5.11K% |
| Earnings Yield | -94.41% |
| Normalized Earnings Yield | -94.41 |